QNZ46
Catalog No: 91006
CAS Number: 1237744-13-6
Purity: 98%
QNZ46 is a noncompetitive and voltage-independent antagonist selective for NR2C/D containing NMDA receptors (IC50 = 6, 3, 229, and >300 M for NR2C, NR2D, NR2A, and NR2B, respectively). Inhibition on NR2C/D containing NMDA receptors is glutamate-binding, but not glycine-binding, dependent.
For research use only. We do not sell to patients.
Chemical Information
| Name | QNZ46 |
|---|---|
| Iupac Chemical Name | 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-benzoic Acid |
| Synonyms | QNZ-46 |
| Molecular Formula | C24H17N3O6 |
| Molecular Weight | 443.408 |
| Smile | COC=1C=C2C(N(C(=NC2=CC1)\C=C\C1=CC(=CC=C1)[N+](=O)[O-])C1=CC=C(C(=O)O)C=C1)=O |
| InChiKey | GNLVJIICVWDSNI-LFYBBSHMSA-N |
| InChi | InChI=1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14H,1H3,(H,29,30)/b12-5+ |
| CAS Number | 1237744-13-6 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
